Management of preterm premature rupture of membranes (except for antibiotherapy): CNGOF preterm premature rupture of membranes guidelines

被引:9
|
作者
Madar, H. [1 ,2 ]
机构
[1] CHU Bordeaux, Hop Pellegrin, Serv Gynecol Obstet, F-33000 Bordeaux, France
[2] CHU Bordeaux, Maternite Alienor Aquitaine Pellegrin, Serv Gynecol Obstet, Pl Amelie Raba Leon, F-33000 Bordeaux, France
来源
关键词
Preterm premature rupture of membranes; Management; Tocolysis; Monitoring; Intrauterine infection; Diagnosis; AMNIOTIC-FLUID VOLUME; RANDOMIZED CONTROLLED-TRIAL; FETAL BIOPHYSICAL PROFILE; C-REACTIVE PROTEIN; PRELABOR RUPTURE; EXPECTANT MANAGEMENT; NEONATAL MORBIDITY; HOME-CARE; INTRAUTERINE INFECTION; AGGRESSIVE TOCOLYSIS;
D O I
10.1016/j.gofs.2018.10.020
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective. - To review the different parts of therapeutic management of viable preterm premature rupture of membranes (PPROM), except the antibiotherapy and birth modalities. Methods. - The Medline, Cochrane Library, and Google Scholar databases over a period from 1980 to September 2018 have been consulted. Results. - When the diagnostic of viable PPROM is reached, the woman should be hospitalized and signs of intrauterine infection (IUI) should be sought (Professional consensus). If cervical assessment appears necessary, speculum, digital examination or cervical ultrasound may be performed (Professional consensus). It is recommended to limit cervical evaluation regardless of the method used (Professional consensus). Initial ultrasound is recommended to determine the fetal presentation, locate the placenta, estimate the fetal weight and the residual amniotic fluid volume (Professional consensus). Performing vaginal and urinary bacteriological sampling at admission is recommended before any antibiotic (Professional consensus). In the case of positive vaginal culture, an antibiogram is necessary since it can guide antibiotherapy in the case of IUI and early onset neonatal bacterial sepsis (Professional consensus). In absence of demonstrated neonatal benefit, there is insufficient evidence to recommend or to not recommend initial tocolysis in PPROM (Grade C). If tocolysis was administered, it is recommended not to prolong it for more than 48 hours (Grade C). Antenatal corticosteroid administration is recommended before 34 weeks of gestation (WG) (Grade A) and magnesium sulfate administration is recommended for women at high risk of imminent preterm birth before 32 WG (Grade A). Vitamin supplementation (vitamins C and E) is not recommended (Professional consensus), and it is recommended not to impose strict bed rest in case of PPROM (Professional consensus). In case of clinical signs of IUI with cerclage, it is recommended to remove the cerclage immediately (Professional consensus). The home care management of clinically stable PPROM after 48 hours of hospital observation can be considered (Professional consensus). During the monitoring of a PPROM, it is recommended to identify elements relating to the diagnosis of IUI (Professional consensus). Conclusion. - The level of evidence and scientific data in the literature concerning the management (except antibiotics) of PPROM are low. Initial management of viable PPROM requires hospitalization. The main objectives of the management are the detection and medical care of maternal and fetal complications. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1029 / 1042
页数:14
相关论文
共 50 条
  • [41] Current management of premature rupture of the membranes in a preterm pregnancy
    Gutierrez Ramos, Miguel
    REVISTA PERUANA DE GINECOLOGIA Y OBSTETRICIA, 2018, 64 (03): : 405 - 413
  • [42] Preterm premature rupture of membranes: Active or expectant management?
    Kayem, G.
    Maillard, F.
    GYNECOLOGIE OBSTETRIQUE & FERTILITE, 2009, 37 (04): : 334 - 341
  • [43] The not so Simple Management of Preterm Premature Rupture of Membranes
    Vidaeff, Alex C.
    GINECO RO, 2009, 5 (02): : 76 - 78
  • [44] Use of amynophillina in the management of preterm premature rupture of membranes
    Di Renzo, G. C.
    Ribiani, E.
    Cruciani, L.
    Gerli, S.
    Mattei, A.
    Luzi, G.
    Burnelli, L.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2006, 28 (7-8): : 372 - 377
  • [45] Antibiotics and the management of preterm premature rupture of the fetal membranes
    Ehrenberg, HM
    Mercer, BM
    CLINICS IN PERINATOLOGY, 2001, 28 (04) : 807 - +
  • [46] EXPECTANT AND ACTIVE MANAGEMENT OF PRETERM PREMATURE RUPTURE OF MEMBRANES
    MALEE, MP
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1992, 19 (02) : 309 - 315
  • [47] PRETERM PREMATURE RUPTURE OF THE MEMBRANES - CONTROVERSIAL MANAGEMENT AND INFECTION
    VILLE, Y
    FERNANDEZ, H
    VINCENT, Y
    FRYDMAN, R
    MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 : 1045 - 1053
  • [48] Role of Azithromycin in the Management of Preterm Premature Rupture of Membranes
    Aguin, Eduardo J.
    Kutinsky, Aaron
    Langen, Elizabeth S.
    REPRODUCTIVE SCIENCES, 2015, 22 : 244A - 244A
  • [49] NEW TECHNOLOGIES FOR THE MANAGEMENT OF PRETERM PREMATURE RUPTURE OF MEMBRANES
    IMANAKA, M
    OGITA, S
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 1992, 19 (02) : 365 - 386
  • [50] Preterm labor, preterm premature rupture of membranes, and chorioamnionitis
    Newton, ER
    CLINICS IN PERINATOLOGY, 2005, 32 (03) : 571 - +